ADARx Pharmaceuticals Statistics
NASDAQ: ADRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.79-1.37 (-9.68%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ADARx Pharmaceuticals by the numbers
ADARx Pharmaceuticals has a market capitalization of $1.42 billion based on 111.19M shares outstanding. With trailing EPS of $-6.75, ADARx Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.4% below its 50-day average and 23.4% below its 200-day average.
Average daily trading volume is 650.63K shares, or about $8.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ADRX valuation vs. peer median
| Metric | ADRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.42B | $1.40B | +2% |
| Avg. volume | 650.63K | 965.94K | -33% |
Peer median across 8 companies: SRPT, KLRA, DMRA, NRIX, TYRA, ANAB, RAPP, QURE.
Valuation
- Market cap
- $1.42B
- EPS (TTM)
- $-6.75
- Shares outstanding
- 111.19M
Price and trading
- Previous close
- 14.16
- Open
- 14.03
- Day range
- 12.66 – 14.86
- 52-week range
- 12.50 – 23.21
- Beta
- —
- Volume
- 708.82K
- Average volume
- 650.63K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 1.42B
- Forward Pe
- -8.31
- Eps
- -6.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 23.21
- Week52 Low
- 12.50
- Avg Volume
- 650.63K
- Shares Outstanding
- 111.19M
- Ma50
- 16.69
- Ma200
- 16.69
- Pct From52w High
- -44.89%
- Pct From52w Low
- 2.32%